AOD9604
AOD9604 (modified human growth hormone fragment 176-191) · ≥98% (HPLC)
AOD9604 is a synthetic 16-residue fragment of human growth hormone (residues 176-191) supplied as a characterized reference material for in-vitro lipid-metabolism research, independent of the GH/IGF-1 axis. Research Use Only.
More in Metabolic signaling
Tirzepatide
Direct-lab pricing · up to 50% below comparable retail listings
Tirzepatide is a synthetic 39-residue lipidated dual GIP/GLP-1 receptor agonist peptide supplied as a characterized reference material for in-vitro receptor and analytical research. For Research Use Only. Not for human or veterinary use.
Retatrutide
Direct-lab pricing · up to 50% below comparable retail listings
Retatrutide (LY3437943) is a synthetic 39-residue lipidated triple-agonist peptide used as a characterized reference material for in-vitro study of GIPR, GLP-1R, and GCGR signaling. For research use only.
Semaglutide
Direct-lab pricing · up to 50% below comparable retail listings
Semaglutide is a synthetic 31-residue lipidated GLP-1 receptor agonist peptide supplied as a characterized reference material for in-vitro receptor and analytical research. For Research Use Only. Not for human or veterinary use.
Research profile & documentation
- Why researchers study it
- Studied in vitro as a fragment-based probe for isolating the lipid-metabolism-associated region of human growth hormone from its growth-promoting (GH-receptor-mediated) activity.
- Mechanism themes in research
- Lipolytic signaling independent of GH-receptor/IGF-1 activationDisulfide-constrained (Cys7–Cys14) fragment stability chemistryStructure-activity mapping of the HGH C-terminal regionAnalytical reference standardization for fragment-peptide identity
- What the evidence does not establish
- Published references are in-vitro or pre-clinical and describe research context only. They do not establish safety, efficacy, or any outcome in humans or animals, and Get Peptides makes no such claims.
- Quality markers
- ≥98% (HPLC)MS identityLot COACold-chain
- What ships
- The sealed lot-controlled vial, a measured ampoule of bacteriostatic water, and a printed handling & reconstitution card — plus the per-lot COA. Everything to prepare it, in one box.
AOD9604 is a synthetic 16-residue fragment related to the C-terminal region of human growth hormone. It is supplied as a characterized reference material for in-vitro peptide chemistry, fragment structure–activity work, and lipid-metabolism research. The page is intentionally framed around laboratory evidence and does not provide human-use or dosing guidance.
Identity and fragment design
AOD9604 is commonly described as a modified human growth-hormone fragment corresponding to residues 176–191, with a disulfide-constrained sequence and a reported molecular weight near 1815.1 g/mol. Public records list CAS 221231-10-3 and a molecular formula of C₇₈H₁₂₃N₂₃O₂₃S₂. Researchers should reconcile catalog data with the lot-specific COA, especially when comparing salts, sequence conventions, or analytical reporting formats.
Why fragments are useful
Peptide fragments can help investigators study one structural region without attributing every observation to the full parent protein. AOD9604 is therefore relevant to experiments that separate C-terminal fragment behavior from growth-hormone-receptor and IGF-axis signaling. This is a research design question: the value of a fragment depends on the assay, controls, purity, and whether the experiment can distinguish direct activity from degradation or matrix effects.
| Full name | AOD9604 (modified human growth hormone fragment 176-191) |
| Research theme | Metabolic signaling |
| CAS number | 221231-10-3 |
| Molecular formula | C₇₈H₁₂₃N₂₃O₂₃S₂ |
| Molecular weight | 1815.1 g/mol |
| Purity | ≥98% (HPLC) |
| Physical form | Lyophilized powder |
| Storage | −20 °C, desiccated, protected from light |
Sequence
Reported research areas
- Lipid-metabolism signaling independent of GH-receptor activation
- Structure-activity studies of HGH C-terminal fragments
- Disulfide-constrained peptide stability chemistry
- Analytical reference standard for peptide identity and purity (HPLC/MS)
Credible sources
- PubChem — AOD9604
- PubMed — AOD9604 and human growth-hormone fragment research
- PubMed — growth hormone residues 176–191
COA with every lot
Each AOD9604 lot is characterized by reversed-phase HPLC for purity and by mass spectrometry for identity, then documented in a per-lot Certificate of Analysis. Unique lot numbers tie the vial back to its synthesis batch and analytical data.
- RP-HPLC purity result (≥98% (HPLC))
- Mass-spectrometry identity confirmation
- Appearance, molecular weight, and storage
- Lot number and testing status
Specimen Certificate of Analysis
| Product | AOD9604 (reference) |
| Lot | HXR-2406-110 |
| Purity (RP-HPLC) | 98%+ |
| Identity (MS) | Confirmed · 1815.1 g/mol |
| Appearance | Lyophilized powder |
| Storage | −20 °C, desiccated |
Representative document. Each lot has its own COA — these are quality documents, not medical claims.
Loading verified reviews…
Reviews come only from buyers we can match to a real order, and each is moderated before it appears. We never publish fabricated or incentivized reviews.